Images

Filter by

Figure 2 Timeline of Major Landmarks in the Journey of Aldosterone Antagonism in Heart Failure
Figure 2: Timeline of Major Landmarks in the Journey of Aldosterone Antagonism in Heart Failure
Figure 1 Mineralocorticoid Receptor Inhibition
Figure 1: Mineralocorticoid Receptor Inhibition
Figure 1 Effects of Glucagon like Peptide 1 Receptor Agonists
Figure 1: Effects of Glucagon-like Peptide-1 Receptor Agonists
Table 1 Characteristics of Studies Exploring the Effects of Glucagon like Peptide 1 Receptor Agonists on Quality of Life in Heart Failure
Table 1: Characteristics of Studies Exploring the Effects of Glucagon-like Peptide-1 Receptor Agonists on Quality of Life in Heart Failure
Figure 1 Effects of Glucagon like Peptide 1 Receptor Agonists on Cardiac Function Exercise Capacity Quality of Life and Clinical Outcomes in Patients With Heart Failure
Figure 1: Effects of Glucagon-like Peptide-1 Receptor Agonists on Cardiac Function, Exercise Capacity, Quality of Life and Clinical Outcomes in Patients With Heart Failure
Figure 2 Haemodynamic Effects Following Sodium glucose Cotransporter 2 Inhibitor Treatment
Figure 2: Haemodynamic Effects Following Sodium-glucose Cotransporter 2 Inhibitor Treatment
Table 3 Effect of Sodium glucose Cotransporter 2 Inhibitors on Systolic Blood Pressure and Diastolic Blood Pressure in HFrEF Patients
Table 3: Effect of Sodium-glucose Cotransporter 2 Inhibitors on Systolic Blood Pressure and Diastolic Blood Pressure in HFrEF Patients
Table 2 Effect of Sodium glucose Cotransporter 2 Inhibitors on Cardiac Filling Pressures in HFpEF Patients
Table 2: Effect of Sodium-glucose Cotransporter 2 Inhibitors on Cardiac Filling Pressures in HFpEF Patients
Table 1 Effect of Sodium glucose Cotransporter 2 Inhibitors on Cardiac Filling Pressures in HFrEF Patients
Table 1: Effect of Sodium-glucose Cotransporter 2 Inhibitors on Cardiac Filling Pressures in HFrEF Patients
Figure 1 Identification of Relevant Studies
Figure 1: Identification of Relevant Studies
Figure 3 Cardiac Function in Pregnancies with Metabolic Disorders
Figure 3: Cardiac Function in Pregnancies with Metabolic Disorders
Figure 2 Left Ventricular Hypertrophy
Figure 2: Left Ventricular Hypertrophy